Reversible high blood CEA and CA19-9 concentrations in a diabetic patient.

about

Association between serum carcinoembryonic antigen level and oxidative stress parameters among diabetic females.The serum levels of tumor marker CA19-9, CEA, CA72-4, and NSE in type 2 diabetes without malignancy and the relations to the metabolic control.

P2860

Q35791975-E9F1A0CC-9B12-43D7-81E1-254F533C448D Q37670750-A35630FF-BB8D-4978-92C0-E453D51429AF

P2860

Reversible high blood CEA and CA19-9 concentrations in a diabetic patient.

Item

http://www.wikidata.org/entity/Q42405453

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Reversible high blood CEA and CA19-9 concentrations in a diabetic patient.

@en

Reversible high blood CEA and CA19-9 concentrations in a diabetic patient.

@nl

type

Item

label

Reversible high blood CEA and CA19-9 concentrations in a diabetic patient.

@en

Reversible high blood CEA and CA19-9 concentrations in a diabetic patient.

@nl

prefLabel

Reversible high blood CEA and CA19-9 concentrations in a diabetic patient.

@en

Reversible high blood CEA and CA19-9 concentrations in a diabetic patient.

@nl

P1476

Reversible high blood CEA and CA19-9 concentrations in a diabetic patient.

@en

P2093

Hong-Da Lin

http://www.w3.org/2001/XMLSchema#string

Pei-Chi Chen

http://www.w3.org/2001/XMLSchema#string

P2860

ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer

Type 2 diabetes mellitus and CA 19-9 levels.

Islet inflammation in type 2 diabetes: from metabolic stress to therapy.

Attenuation of endocrine-exocrine pancreatic communication in type 2 diabetes: pancreatic extracellular matrix ultrastructural abnormalities.

Elevated levels of CA 19-9 and CEA in pancreatic cancer-associated diabetes.

Clinical review 63: Diabetes and pancreatic cancer: clues to the early diagnosis of pancreatic malignancy.

Influence of metabolic disturbances of diabetes mellitus on serum CA 19-9 tumor marker.

Diabetes mellitus and pancreatic cancer in a population-based case-control study in the San Francisco Bay Area, California.

CA 19-9 level in patients with type 2 diabetes mellitus and its relation to the metabolic control and microvascular complications.

Elevated serum CA19-9 levels in poorly controlled diabetic patients.

P31

scholarly article

P356

10.3402/LJM.V7I0.19572

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2012-10-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

232722344

http://www.w3.org/2001/XMLSchema#string

P698

23105951

http://www.w3.org/2001/XMLSchema#string

P932

3480960

http://www.w3.org/2001/XMLSchema#string

Reversible high blood CEA and CA19-9 concentrations in a diabetic patient.

about

P2860

P2860

Reversible high blood CEA and CA19-9 concentrations in a diabetic patient.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P31

P356

P478

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P31

P356

P478

P577

P5875

P698

P932